在瘤学临床试验中解释免疫性
Peter R Galle1, Martin Reck2, David J Pinato3
1Director of the I. Medical Department at the University Medical Center, Johannes Gutenberg University, Mainz, Germany.
Cancer treatment reviews
|August 31, 2025
概括
抗药抗体 (ADA) 在瘤学中影响治疗的有效性和安全性. 专注于ADAs的临床相关性,而不仅仅是它们的存在,对于癌症治疗中的患者护理至关重要.
科学领域:
- 癌症学
- 免疫学
- 药理学
背景情况:
- 在瘤学中,治疗性蛋白质的免疫性可能导致抗药抗体 (ADAs).
- 可以显著影响药物的药理动力学,药理动力学,疗效和安全性.
- 在瘤学中评估免疫性是复杂的,因为测定敏感性,药物干扰和患者采样频率.
研究的目的:
- 审查瘤学中免疫性评估的背景和命名.
- 突出瘤学研究中的ADA检测和解释的复杂性和局限性.
- 要强调ADAs的临床相关性,而不是仅仅是它们的发生率.
主要方法:
- 对瘤临床试验中的免疫性现有文献的综述.
- 影响ADA检测的因素分析,包括检测方法和采样计划.
- 讨论使数据解释复杂的患者特异性因素和并发性治疗.
主要成果:
- 在瘤学中,免疫性常用命名有局限性.
- ADA的临床影响比单独存在更为关键.
- 解释挑战包括患者因素,治疗方法和生存偏见.
结论:
- 准确解释免疫性数据需要考虑测定方法,研究设计和采样频率.
- 临床医生必须评估ADA的临床相关性,以便明智地做出治疗决定.
- 在瘤学中,重点应该是ADA的临床影响,而不仅仅是其发生率.
相关概念视频
Tumor Immunotherapy
659
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
659
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
174
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
174
Cytotoxic T Cells-mediated Immune Response
1.9K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
1.9K
Cancer Vaccines
509
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
509
Mutagenicity and Carcinogenicity
1.4K
Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
1.4K
Clinical Trials
7.8K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
7.8K


